Director, Portfolio & Product Strategy, NS
Novartis
9 hours ago
Remote friendly (East Hanover, NJ)
United States
Marketing
Key Responsibilities:
- Partner with TA Head, GMs, and ED to build forward-looking competitive readiness plans (strategy, tactical, scenario planning) based on external competitive environment and internal product/portfolio strategies.
- Ensure product/portfolio teams are ready to anticipate and act on macro-market changes and competitor launches/strategies in a legal and compliant manner.
- Provide input on assets to S&G, Development, and BioMedical Research to maximize commercial viability and launch value generation, including Life Cycle Management (LCM) planning and Integrated Evidence Plans/LCM Plans for early pipeline assets.
- Support US BD&L and US Market Access with country-level input for BD&L evaluations (e.g., TPP development, stakeholder research, DC/IMB prep).
- Support strategic evaluations/initiatives and provide TAL input (e.g., white/position papers, competitive levers, portfolio mix gaps, emerging unmet needs).
- Support/lead transition of late-stage pipeline assets from S&G to US Commercial 6+ months before FDP; prepare FDP submission package and represent US Commercial needs at critical forums.
Qualifications:
- Education: Bachelor’s required (relevant); MBA/advanced degree preferred.
- Experience (Required): 8+ years commercial experience with multiple functional roles (2+ types; sales/marketing/strategy/market access/medical preferred); recent US market commercialization or GM experience elsewhere; experience partnering with Medical Affairs and/or Development.
- Skills: autonomy, creative problem-solving, portfolio approach, competitive readiness leadership.
- Desirable: multiple therapeutic areas; Market Access; ability to influence leaders 1–2 levels above; comfort in complex/ambiguous environments with tight timelines.
Compensation/Benefits (as stated):
- Salary range: $185,500–$344,500/year; performance-based cash incentive; possible annual equity awards. US-based eligible employees receive comprehensive benefits and time off.
- Partner with TA Head, GMs, and ED to build forward-looking competitive readiness plans (strategy, tactical, scenario planning) based on external competitive environment and internal product/portfolio strategies.
- Ensure product/portfolio teams are ready to anticipate and act on macro-market changes and competitor launches/strategies in a legal and compliant manner.
- Provide input on assets to S&G, Development, and BioMedical Research to maximize commercial viability and launch value generation, including Life Cycle Management (LCM) planning and Integrated Evidence Plans/LCM Plans for early pipeline assets.
- Support US BD&L and US Market Access with country-level input for BD&L evaluations (e.g., TPP development, stakeholder research, DC/IMB prep).
- Support strategic evaluations/initiatives and provide TAL input (e.g., white/position papers, competitive levers, portfolio mix gaps, emerging unmet needs).
- Support/lead transition of late-stage pipeline assets from S&G to US Commercial 6+ months before FDP; prepare FDP submission package and represent US Commercial needs at critical forums.
Qualifications:
- Education: Bachelor’s required (relevant); MBA/advanced degree preferred.
- Experience (Required): 8+ years commercial experience with multiple functional roles (2+ types; sales/marketing/strategy/market access/medical preferred); recent US market commercialization or GM experience elsewhere; experience partnering with Medical Affairs and/or Development.
- Skills: autonomy, creative problem-solving, portfolio approach, competitive readiness leadership.
- Desirable: multiple therapeutic areas; Market Access; ability to influence leaders 1–2 levels above; comfort in complex/ambiguous environments with tight timelines.
Compensation/Benefits (as stated):
- Salary range: $185,500–$344,500/year; performance-based cash incentive; possible annual equity awards. US-based eligible employees receive comprehensive benefits and time off.